A

argenx

Develops antibody-based therapies for autoimmune diseases

Trial Operations Excellence & Innovation Lead

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A Bachelor's or Master's degree in Life Sciences, Biomedical Sciences, Pharmacy, Nursing, Medicine, or a related discipline is required.
  • A minimum of 12 years of global clinical operations experience is required.
  • Demonstrated experience leading strategic change initiatives across multiple functions and geographies is required.
  • Strong experience with clinical trial technology platforms and operational innovation is required.
  • A strong understanding of ICH Good Clinical Practice, global regulations, and sponsor oversight requirements is required.
  • Strategic leadership and the ability to define and execute transformational change are required.
  • A strong understanding of drug development and global clinical trial execution is required.
  • Demonstrated operational excellence and process improvement expertise are required.
  • Strong stakeholder management and influencing skills across all organizational levels are required.
  • Excellent business acumen and portfolio-level thinking are required.
  • Strong change management and organizational transformation capabilities are required.
  • Strong analytical and problem-solving skills are required.

Responsibilities

  • Define and execute the Trial Operations strategic transformation roadmap aligned with argenx vision.
  • Identify future capability requirements needed to support portfolio growth, increasingly complex trial designs, and evolving regulatory expectations.
  • Serve as a thought leader for innovative trial operations approaches and emerging technologies, including AI technology.
  • Translate strategic priorities into executable programs with measurable business outcomes.
  • Partner with Trial Operations leadership to establish long-term operational capability plans.
  • Establish a continuous improvement culture throughout Trial Operations.
  • Drive standardization, simplification, and optimization of operational processes.
  • Sponsor and oversee major process improvement initiatives.
  • Act as a thought partner to the eCOA Center of Excellence Lead.
  • Establish and lead Centers of Excellence for emerging operational capabilities, including imaging, Digital Health Technologies, wearables and remote monitoring solutions, hybrid and decentralized trial methodologies, and AI-enabled operational tools.
  • Develop implementation frameworks enabling scalable adoption across the portfolio.
  • Oversee cross-asset and cross-indication strategic initiatives requiring coordinated execution across multiple development programs.
  • Partner with Asset Teams, CODLs, FCODLs, and Program Leadership to identify opportunities for harmonization and standardization.
  • Drive portfolio-wide solutions that reduce operational complexity and accelerate development timelines.
  • Serve as the primary Trial Operations representative for enterprise-wide operational transformation initiatives and act as the primary point of contact for contract research organization partners to drive innovation and digital transformation.
  • Ensure lessons learned and best practices are systematically leveraged across assets and indications.
  • Continuously evaluate external industry trends, technologies, and best practices.
  • Collaborate with Digital, Clinical Development, Biometrics, Medical Affairs, Regulatory, and Quality teams to operationalize new capabilities.
  • Assess emerging solutions for feasibility, scalability, risk, and business benefit.
  • Lead proof-of-concept activities and operational deployment plans.
  • Develop implementation strategies that balance innovation with operational simplicity and regulatory compliance.
  • Establish governance frameworks for strategic initiatives and Centers of Excellence.
  • Present recommendations and progress updates to senior leadership.
  • Ensure alignment across capabilities, indications, and cross-functional stakeholders.
  • Facilitate decision-making for complex and enterprise-level prioritization topics.
  • Act as an escalation point for strategic operational challenges.
  • Represent Trial Operations in relevant cross-functional governance forums and strategic discussions to ensure operational perspectives are integrated into enterprise decisions, capability roadmaps, and portfolio prioritization.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs